ABOUT FUTURE FIELDS
Future Fields is pioneering the next generation of biomanufacturing—using nature’s most efficient bioreactor to lead the way in complex protein expression.
At the core of our work is the EntoEngine®, our proprietary platform that leverages whole, genetically engineered fruit flies (Drosophila melanogaster). By embracing the simple elegance of a model organism backed by over a century of research, we bypass the heavy infrastructure and high costs of traditional cell culture. The result is a flexible, highly scalable platform engineered to express complex recombinant proteins that traditional systems struggle to produce.
To meet global demand, we built Instar 1.0 next door to our HQ in Edmonton, Canada. This first-of-its-kind facility translates our technology into reliable, high-capacity production. We partner closely with clients across life sciences, agriculture, and food innovation to deliver quality-assured biomolecules that advance breakthrough science.
We care deeply about our people, our partners, and the planet. As a My Green Lab Green-certified lab, a 1% for the Planet business member, and a participant in the UN Global Compact, we hold ourselves to rigorous environmental and professional standards. Powered by people and fly by design, we bring care, quality, and proven science to everything we build.
Explore our platform, services, and vision at futurefields.io.
INDUSTRY INSIGHTS
-
![Overview Of Recombinant Protein Expression Systems_Future Fields]( "Overview Of Recombinant Protein Expression Systems")
Compare leading protein expression platforms and see how complexity, scalability, cost, and quality shape the path to commercial production.
-
![Future Fields Presents At PepTalk 2026]( "Sequence To Scale In 7 Months | Future Fields Presents At PepTalk 2026")
Learn how an insect-based expression platform overcomes protein manufacturing challenges, enabling rapid scale-up of complex recombinant proteins from sequence to commercial production in just seven months.
-
![The Next Evolution In Advanced Biomanufacturing]( "The Next Evolution In Advanced Biomanufacturing")
How do we produce recombinant proteins in transgenic fruit flies? Matt Anderson-Baron, PhD, provides the deep-dive of Future Fields' novel biomanufacturing process.
-
![How To Reconstitute Lyophilized Proteins]( "How To Reconstitute Lyophilized Proteins")
Master lyophilized protein reconstitution with tips for dilution, mixing, handling, and storage.
-
![Resolving In-Vitro Diagnostic Supply Chain Constraints_FutureFields]( "Resolving In-Vitro Diagnostic Supply Chain Constraints")
Explore strategies for securing recombinant proteins while addressing supply continuity, batch consistency, scale-up challenges, and quality requirements for clinical validation and commercialization.
-
![Transgenic Fruit Flies vs. Cell Lines Eliminating Bioreactor Bottlenecks_Future Fields]( "Transgenic Fruit Flies vs. Cell Lines: Eliminating Bioreactor Bottlenecks")
Overcome biomanufacturing tradeoffs with expression strategies that enhance stability, scalability, and production consistency.
-
![GettyImages-1389546565-lab-bioreactor]( "Beyond The Bioreactor Scaling CGT Ancillary Materials With The EntoEngine™")
Growing demand for cell and gene therapies is increasing pressure on cytokine production. Explore interleukin manufacturing, quality, consistency, safety, scalability, and supply reliability.
-
![From Sequence To Scale In Seven Months_Future Fields]( "From Sequence To Scale In Seven Months")
Accelerate recombinant protein development from sequence to scale while maintaining stable expression, manufacturing efficiency, and critical quality attributes.
-
![Manufacturing Glycosylated_Future Fields]( "Manufacturing Glycosylated Erythropoietin Without 𝛼1,3-Fucosylation")
See how expression hosts affect recombinant EPO glycosylation, bioactivity, and consistency, with reproducible N-glycan profiles and absence of α1,3-linked fucosylation.
-
![Characterization Of Fly-Derived Prolactin_Future Fields]( "Characterization Of Fly-Derived Prolactin: Insights Into Glycosylation And Activity")
Explore how D. mel-derived human prolactin (hPRL) compares with hPRL expressed in E. coli and HEK293 cells through detailed physico-chemical and biological characterization.
-
![Exploring the Genetic Tools Enabling Protein Expression in Fruit Flies_FutureFields]( "Exploring The Genetic Tools Enabling Protein Expression In Fruit Flies")
Fruit fly genetics enables precise, scalable protein expression through stable integration, targeted control, inducible regulation, and heritable systems.
-
![The Art of Protein Expression-FutureFields]( "The Art Of Protein Expression: A Guide To Understanding Difficult-To-Express Proteins")
Protein expression failures often result from misfolding, PTMs, assembly issues, insolubility, and toxicity. Understanding their interplay can improve yields.
CONTACT INFORMATION
Future Fields
11130 105 Ave NW
Edmonton, AB T5H 0L5
CANADA
SOLUTIONS
-
![Inside look at a fruit fly biomanufacturing facility]( "Inside Look At A Fruit Fly Biomanufacturing Facility | Future Fields Instar 1.0 Biofactory")
Achieve reliable, on-demand protein production with a manufacturing approach that minimizes scale-up risk from R&D through commercialization.
-
![process control for monoclonal antibodies, recombinant proteins, probiotics, GLP-1 production-GettyImages-2281853896]( "Rescuing Proteins With Scalable Insect Expression")
Overcome protein expression bottlenecks with a scalable insect-based platform that delivers faster development, predictable scale-up, and consistent manufacturing.
-
![GettyImages-675822772-scientist-holding-book-with-bioreactor]( "The EntoEngine: Fruit Flies For Advanced Biomanufacturing")
Produce recombinant proteins at scale with stable expression, flexible batch sizes, and streamlined manufacturing.
-
![cellular protein synthesis. mRNA vaccine research-GettyImages-2249044433]( "Secure Scalable Supply Of Critical Assay Proteins For Diagnostic R&D")
Our custom expression platform directly addresses the primary host limitations in early-to-mid stage assay development:
